The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Tumor Ablation Market Research Report 2025

Global Tumor Ablation Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1735468

No of Pages : 79

Ask Your Query

Synopsis

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.

The global Tumor Ablation market was valued at US$ 537 million in 2023 and is anticipated to reach US$ 1088.9 million by 2030, witnessing a CAGR of 10.5% during the forecast period 2024-2030.

Global Tumor Ablation key players include Chongqing Haifu Medical, HealthTronics, AngioDynamics, Boston Scientific, Medtronic, etc. Global top five manufacturers hold a share about 55%.

North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent. In terms of product, Radiofrequency (RF) Ablation is the largest segment, with a share about 40%. And in terms of application, the largest application is Lung Cancer, followed by Liver Cancer, Kidney Cancer, etc.

This report aims to provide a comprehensive presentation of the global market for Tumor Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Ablation.

Report Scope

The Tumor Ablation market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Ablation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tumor Ablation manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company (Partial List):

  • Angiodynamics
  • Medtronic
  • Boston Scientific
  • Misonix
  • Sonacare Medical
  • EDAP TMS
  • Chongqing Haifu Medical
  • HealthTronics
  • J &J

Segment by Type

  • Radiofrequency (RF) Ablation
  • Microwave Ablation
  • Cryoablation
  • Other Technologies

Segment by Application

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tumor Ablation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tumor Ablation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Tumor Ablation Market Overview
1.1 Product Overview and Scope of Tumor Ablation
1.2 Tumor Ablation Segment by Type
1.2.1 Global Tumor Ablation Market Value Comparison by Type (2024-2030)
1.2.2 Radiofrequency (RF) Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Other Technologies
1.3 Tumor Ablation Segment by Application
1.3.1 Global Tumor Ablation Market Value by Application: (2024-2030)
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.4 Global Tumor Ablation Market Size Estimates and Forecasts
1.4.1 Global Tumor Ablation Revenue 2019-2030
1.4.2 Global Tumor Ablation Sales 2019-2030
1.4.3 Global Tumor Ablation Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tumor Ablation Market Competition by Manufacturers
2.1 Global Tumor Ablation Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tumor Ablation Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tumor Ablation Average Price by Manufacturers (2019-2024)
2.4 Global Tumor Ablation Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tumor Ablation, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumor Ablation, Product Type & Application
2.7 Tumor Ablation Market Competitive Situation and Trends
2.7.1 Tumor Ablation Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tumor Ablation Players Market Share by Revenue
2.7.3 Global Tumor Ablation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tumor Ablation Retrospective Market Scenario by Region
3.1 Global Tumor Ablation Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tumor Ablation Global Tumor Ablation Sales by Region: 2019-2030
3.2.1 Global Tumor Ablation Sales by Region: 2019-2024
3.2.2 Global Tumor Ablation Sales by Region: 2025-2030
3.3 Global Tumor Ablation Global Tumor Ablation Revenue by Region: 2019-2030
3.3.1 Global Tumor Ablation Revenue by Region: 2019-2024
3.3.2 Global Tumor Ablation Revenue by Region: 2025-2030
3.4 North America Tumor Ablation Market Facts & Figures by Country
3.4.1 North America Tumor Ablation Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tumor Ablation Sales by Country (2019-2030)
3.4.3 North America Tumor Ablation Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tumor Ablation Market Facts & Figures by Country
3.5.1 Europe Tumor Ablation Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tumor Ablation Sales by Country (2019-2030)
3.5.3 Europe Tumor Ablation Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Ablation Market Facts & Figures by Country
3.6.1 Asia Pacific Tumor Ablation Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tumor Ablation Sales by Country (2019-2030)
3.6.3 Asia Pacific Tumor Ablation Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tumor Ablation Market Facts & Figures by Country
3.7.1 Latin America Tumor Ablation Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tumor Ablation Sales by Country (2019-2030)
3.7.3 Latin America Tumor Ablation Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tumor Ablation Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Ablation Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tumor Ablation Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tumor Ablation Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumor Ablation Sales by Type (2019-2030)
4.1.1 Global Tumor Ablation Sales by Type (2019-2024)
4.1.2 Global Tumor Ablation Sales by Type (2025-2030)
4.1.3 Global Tumor Ablation Sales Market Share by Type (2019-2030)
4.2 Global Tumor Ablation Revenue by Type (2019-2030)
4.2.1 Global Tumor Ablation Revenue by Type (2019-2024)
4.2.2 Global Tumor Ablation Revenue by Type (2025-2030)
4.2.3 Global Tumor Ablation Revenue Market Share by Type (2019-2030)
4.3 Global Tumor Ablation Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tumor Ablation Sales by Application (2019-2030)
5.1.1 Global Tumor Ablation Sales by Application (2019-2024)
5.1.2 Global Tumor Ablation Sales by Application (2025-2030)
5.1.3 Global Tumor Ablation Sales Market Share by Application (2019-2030)
5.2 Global Tumor Ablation Revenue by Application (2019-2030)
5.2.1 Global Tumor Ablation Revenue by Application (2019-2024)
5.2.2 Global Tumor Ablation Revenue by Application (2025-2030)
5.2.3 Global Tumor Ablation Revenue Market Share by Application (2019-2030)
5.3 Global Tumor Ablation Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Angiodynamics
6.1.1 Angiodynamics Corporation Information
6.1.2 Angiodynamics Description and Business Overview
6.1.3 Angiodynamics Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Angiodynamics Tumor Ablation Product Portfolio
6.1.5 Angiodynamics Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Tumor Ablation Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boston Scientific Tumor Ablation Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 Misonix
6.4.1 Misonix Corporation Information
6.4.2 Misonix Description and Business Overview
6.4.3 Misonix Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Misonix Tumor Ablation Product Portfolio
6.4.5 Misonix Recent Developments/Updates
6.5 Sonacare Medical
6.5.1 Sonacare Medical Corporation Information
6.5.2 Sonacare Medical Description and Business Overview
6.5.3 Sonacare Medical Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sonacare Medical Tumor Ablation Product Portfolio
6.5.5 Sonacare Medical Recent Developments/Updates
6.6 EDAP TMS
6.6.1 EDAP TMS Corporation Information
6.6.2 EDAP TMS Description and Business Overview
6.6.3 EDAP TMS Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.6.4 EDAP TMS Tumor Ablation Product Portfolio
6.6.5 EDAP TMS Recent Developments/Updates
6.7 Chongqing Haifu Medical
6.6.1 Chongqing Haifu Medical Corporation Information
6.6.2 Chongqing Haifu Medical Description and Business Overview
6.6.3 Chongqing Haifu Medical Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chongqing Haifu Medical Tumor Ablation Product Portfolio
6.7.5 Chongqing Haifu Medical Recent Developments/Updates
6.8 HealthTronics
6.8.1 HealthTronics Corporation Information
6.8.2 HealthTronics Description and Business Overview
6.8.3 HealthTronics Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.8.4 HealthTronics Tumor Ablation Product Portfolio
6.8.5 HealthTronics Recent Developments/Updates
6.9 J &J
6.9.1 J &J Corporation Information
6.9.2 J &J Description and Business Overview
6.9.3 J &J Tumor Ablation Sales, Revenue and Gross Margin (2019-2024)
6.9.4 J &J Tumor Ablation Product Portfolio
6.9.5 J &J Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Ablation Industry Chain Analysis
7.2 Tumor Ablation Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Ablation Production Mode & Process
7.4 Tumor Ablation Sales and Marketing
7.4.1 Tumor Ablation Sales Channels
7.4.2 Tumor Ablation Distributors
7.5 Tumor Ablation Customers
8 Tumor Ablation Market Dynamics
8.1 Tumor Ablation Industry Trends
8.2 Tumor Ablation Market Drivers
8.3 Tumor Ablation Market Challenges
8.4 Tumor Ablation Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock